LONDON: AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020. With today’s agreement, the IVA aims to accelerate the supply of the vaccine…
All posts tagged AstraZeneca
The US Oncology Network finds cancer drug may benefit advanced COVID-19 patients
HOUSTON: Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib (Calquence) by researchers, including physicians within The US Oncology Network. Results of the exploratory research, which was conducted in collaboration with AstraZeneca (AZ) and the National Institutes of Health (NIH), appear in Science Immunology. Nineteen patients with…
Bevespi Aerosphere approved in China for patients with COPD
LONDON: AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in China as a maintenance treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. The approval by the National Medical Products Administration (NMPA) was based on positive results from the Phase III PINNACLE 4 trial in which Bevespi…
DeepMatter collaborates with AstraZeneca to improve productivity of compound synthesis
LONDON: DeepMatter Group has collaborated with AstraZeneca to use innovative digital technologies with the aim of improving the productivity and reproducibility of compound synthesis. DeepMatter’s long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics Scientists…
AstraZeneca divests rights to Seroquel and Seroquel XR for $35 million
LONDON, UK: AstraZeneca has agreed to sell the commercial rights to Seroquel and Seroquel XR in the US and Canada to Cheplapharm Arzneimittel GmbH. Cheplapharm will make an upfront payment of $35 million to AstraZeneca and may also make future sales-contingent payments of up to $6 million. Seroquel and Seroquel XR, used primarily to treat…